UPDATE 1-FDA approves Eli Lilly's blood cancer drug
Yahoo! Finance
Eli Lilly and Co said on Friday the U.S. health regulator approved its drug for the treatment of a rare form of blood cancer. The Food and Drug Administration gave accelerated approval to Jaypirca for the treatment of adults mantle cell lymphoma after at least two lines of therapy.
Continue Reading